L 196/38 Official Journal of the European Communities 25.7.2002 COMMISSION DECISION of 16 April 2002 on the allocation of quantities of controlled substances allowed for essential uses in the Commu- nity in 2002 under Regulation (EC) No 2037/2000 of the European Parliament and of the Council (notified under document number C(2002) 1410) (Only the Danish, Dutch, English, Finnish, French, German, Italian, Portuguese, Spanish and Swedish texts are authentic) (Text with EEA relevance) (2002/612/EC) THE COMMISSION OF THE EUROPEAN COMMUNITIES, Having regard to the Treaty establishing the European Community, Having regard to Regulation (EC) No 2037/2000 of the European Parliament and of the Council of 29 June 2000 on substances that deplete the ozone layer (!), as last amended by Regulation (EC) No 2039/2000 (3), and in particular to Articles 3 and 7 thereof; Whereas: (1)  The Community has already phased out the production and consumption of chlorofluorocarbons, other fully halogenated chlorofluorocarbons, halons, carbon tetra- chloride, 1,1,1-trichloroethane and hydrobromofluoro- carbons. (2)  Each year the Commission has to determine what the essential uses of these controlled substances are, the quantities that may be used and the companies that may use them. (3)  Decision IV[25 of the Parties to the Montreal Protocol on substances that deplete the ozone layer, hereinafter ‘Montreal Protocol, sets out the criteria used by the Commission for determining any essential uses. (4)  Decision XII/9 of the Parties to the Montreal Protocol authorises the levels of production and consumption necessary to satisfy essential uses of controlled substances for metered dose inhalers (MDIs) for the treat- ment of asthma and chronic obstructive pulmonary disease (COPD). (5)  Decision X[19 of the Parties to the Montreal Protocol authorises the production and consumption necessary to satisfy essential uses of controlled substances for labora- tory and analytical uses as listed in Annex IV to the report of the seventh meeting of the Parties, subject to the conditions set out in Annex II to the report of the sixth meeting of the Parties, Decision VII/11 and Deci- sion XI/15 of the Parties to the Montreal Protocol. () OJ L 244, 29.9.2000, p. 1. () OJ L 244, 29.9.2000, p. 26. (6)  Decision VIII/9 of the Parties to the Montreal Protocol allows the Secretariat to authorise, in an emergency situation, consumption of quantities not exceeding 20 tonnes of ozone-depleting substances (ODS) for essential uses on application by a Party, and the Community applied for such an emergency use to be allowed for oil- in-water testing in 2002. (7)  The Commission has published a notice () to those companies in the Community that intend to use controlled substances for essential uses in the Commu- nity in 2002, and has received declarations on intended essential uses of controlled substances in 2002. (8)  To meet the need for controlled substances for essential uses, production may be authorised in accordance with Article 3(5) of Regulation (EC) No 2037/2000 or an import may be licensed in accordance with Article 6 of that Regulation. (9)  The measures provided for in this Decision are in accor- dance with the opinion of the Committee established pursuant to Article 18 of Regulation (EC) No 2037/ 2000, HAS ADOPTED THIS DECISION: Article 1 1. The quantity of controlled substances of group I (chloro- fluorocarbons 11, 12, 113, 114 and 115) subject to Regulation (EC) No 2037/2000 which may be used for essential medical uses in the Community in 2002 shall be 2 558 948,00 ODP (ozone depletion potential) weighted kilograms. 2. The quantity of controlled substances of group I (chloro- fluorocarbons 11, 12, 113, 114 and 115) and group II (other fully halogenated chlorofluorocarbons) subject to Regulation (EC) No 2037/2000 which may be used for essential laboratory uses in the Community in 2002 shall be 135 971,59 ODP weighted kilograms. () 0J C 205, 21.7.2001, p. 2.